论文部分内容阅读
目的:探究支气管应用雾化治疗吸入布地奈德与沙丁胺醇治疗的临床效果。方法:选取我院自2014年1月到2016年12月门诊收治的100例支气管哮喘的患者作为研究对象,并进行随机分组,分为对照组和观察组,每组各50例,其中对照组患者在常规治疗的基础上接受雾化吸入沙丁胺醇单独治疗,观察组患者在常规治疗的基础上接受布地奈德与沙丁胺醇联合吸入雾化治疗。治疗7天为一个疗程,连续治疗1-2个疗程,观察并比较两组患者之间的临床疗效。结果:治疗后,观察组患者的总有效率为94.00%明显高于对照组患者的总有效率84.00%,差异具有统计学意义(p<0.05)。结论 :支气管哮喘患者在常规治疗的基础上应用雾化吸入布地奈德与沙丁胺醇治疗具有突出疗效,可在今后的临床工作中进行广泛的推广工作。
Objective: To investigate the clinical effect of inhalation of budesonide and salbutamol treated by bronchial atomization therapy. Methods: A total of 100 patients with bronchial asthma admitted from our hospital from January 2014 to December 2016 were selected as the study subjects and randomly divided into control group and observation group, with 50 cases in each group. The control group Patients were treated with inhaled albuterol alone on a routine treatment basis. Patients in the observation group received inhaled budesonide combined with salbutamol inhalation on a routine basis. Treatment for 7 days for a course of treatment for 1-2 courses of continuous treatment, observe and compare the clinical efficacy between the two groups of patients. Results: After treatment, the total effective rate of the observation group was 94.00%, which was significantly higher than that of the control group (84.00%), the difference was statistically significant (p <0.05). Conclusion: Bronchial asthma patients have the outstanding curative effect on the basis of routine treatment with budesonide inhalation and salbutamol inhalation, which can be extensively popularized in future clinical work.